
### [MONDO:0000073](http://purl.obolibrary.org/obo/MONDO_0000073)
**Label:** nail disorder, nonsyndromic congenital

**Subclasses:** [MONDO:0007900](http://purl.obolibrary.org/obo/MONDO_0007900) (nonsyndromic congenital nail disorder 3), [MONDO:0007867](http://purl.obolibrary.org/obo/MONDO_0007867) (nonsyndromic congenital nail disorder 2), [MONDO:0013596](http://purl.obolibrary.org/obo/MONDO_0013596) (nonsyndromic congenital nail disorder 10), [MONDO:0013592](http://purl.obolibrary.org/obo/MONDO_0013592) (nonsyndromic congenital nail disorder 9), [MONDO:0011595](http://purl.obolibrary.org/obo/MONDO_0011595) (nonsyndromic congenital nail disorder 7), [MONDO:0007135](http://purl.obolibrary.org/obo/MONDO_0007135) (nonsyndromic congenital nail disorder 6), [MONDO:0008125](http://purl.obolibrary.org/obo/MONDO_0008125) (nonsyndromic congenital nail disorder 5), [MONDO:0011852](http://purl.obolibrary.org/obo/MONDO_0011852) (nonsyndromic congenital nail disorder 8), [MONDO:0008798](http://purl.obolibrary.org/obo/MONDO_0008798) (nonsyndromic congenital nail disorder 4), [MONDO:0008060](http://purl.obolibrary.org/obo/MONDO_0008060) (nonsyndromic congenital nail disorder 1), 

**Mapped go classes:** [GO:0035880](http://purl.obolibrary.org/obo/GO_0035880) (embryonic nail plate morphogenesis), [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane), [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity), [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding), [GO:0033340](http://purl.obolibrary.org/obo/GO_0033340) (pelvic fin development), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0001786](http://purl.obolibrary.org/obo/GO_0001786) (phosphatidylserine binding), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0051482](http://purl.obolibrary.org/obo/GO_0051482) (positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0033335](http://purl.obolibrary.org/obo/GO_0033335) (anal fin development), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0035878](http://purl.obolibrary.org/obo/GO_0035878) (nail development), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0033338](http://purl.obolibrary.org/obo/GO_0033338) (medial fin development), [GO:0032962](http://purl.obolibrary.org/obo/GO_0032962) (positive regulation of inositol trisphosphate biosynthetic process), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0033337](http://purl.obolibrary.org/obo/GO_0033337) (dorsal fin development), [GO:0033336](http://purl.obolibrary.org/obo/GO_0033336) (caudal fin development), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0004629](http://purl.obolibrary.org/obo/GO_0004629) (phospholipase C activity), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0010701](http://purl.obolibrary.org/obo/GO_0010701) (positive regulation of norepinephrine secretion), [GO:0032794](http://purl.obolibrary.org/obo/GO_0032794) (GTPase activating protein binding), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding), [GO:1900274](http://purl.obolibrary.org/obo/GO_1900274) (regulation of phospholipase C activity), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0004435](http://purl.obolibrary.org/obo/GO_0004435) (phosphatidylinositol phospholipase C activity), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0070300](http://purl.obolibrary.org/obo/GO_0070300) (phosphatidic acid binding), [GO:0033278](http://purl.obolibrary.org/obo/GO_0033278) (cell proliferation in midbrain), [GO:0060071](http://purl.obolibrary.org/obo/GO_0060071) (Wnt signaling pathway, planar cell polarity pathway), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0050896](http://purl.obolibrary.org/obo/GO_0050896) (response to stimulus), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0051480](http://purl.obolibrary.org/obo/GO_0051480) (regulation of cytosolic calcium ion concentration), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0048105](http://purl.obolibrary.org/obo/GO_0048105) (establishment of body hair planar orientation), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0005544](http://purl.obolibrary.org/obo/GO_0005544) (calcium-dependent phospholipid binding), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051592](http://purl.obolibrary.org/obo/GO_0051592) (response to calcium ion), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0001736](http://purl.obolibrary.org/obo/GO_0001736) (establishment of planar polarity), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0035567](http://purl.obolibrary.org/obo/GO_0035567) (non-canonical Wnt signaling pathway), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.84%
- [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding) 51.39%
- [GO:0070300](http://purl.obolibrary.org/obo/GO_0070300) (phosphatidic acid binding) 51.39%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.39%
- [GO:0044389](http://purl.obolibrary.org/obo/GO_0044389) (ubiquitin-like protein ligase binding) 51.39%
- [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity) 51.39%
- [GO:0032794](http://purl.obolibrary.org/obo/GO_0032794) (GTPase activating protein binding) 51.39%
- [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding) 51.39%
- [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding) 51.39%
- [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding) 51.39%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.39%
- [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane) 51.39%
- [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding) 51.39%
- [GO:0005544](http://purl.obolibrary.org/obo/GO_0005544) (calcium-dependent phospholipid binding) 51.39%
- [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity) 51.39%


